Categories Analysis, Technology

Stock Watch: Why you should add Paychex (PAYX) to your watchlist

The company will be publishing fourth-quarter results on June 29, before the opening bell

Paychex, Inc. (NASDAQ: PAYX), a leading provider of integrated human capital management solutions, has expanded its business constantly over the years by diversifying the portfolio and through buyouts. The company has performed better than the broader market this year, thanks to its sticky client base and record-high retention levels.

The Rochester-based company’s stock climbed to a record high early last month, before retreating in the following weeks. It had gained steadily since the beginning of 2022, after making a weak start to the year. Interestingly, the macro headwinds have had a limited impact on PAYX, which can be attributed to the company’s effective business model.

Dividend Hike

The primary factor that makes the stock an attractive investment is the stable earnings performance. Last month, the board of directors declared a 20% hike in the quarterly dividend, which translates into a yield of around 2.5%. The company rewards shareholders regularly through share repurchases and dividends. However, at the current stock price of $120, the valuation looks high.


Earnings: Highlights of DocuSign’s Q4 2022 financial results


Considering the market uncertainty and macro headwinds, it would be a good idea to wait until conditions become more favorable before buying PAYX. Meanwhile, prospective investors can continue to keep an eye on it. That said, the stock’s resilience to the financial crisis and market selloff make it a good buying option for long-term investors.

 

Paychex Q3 2022 earnings infographic

“We’re finding good response to our SEM and SEO investments on brand and also the products that are worked well with us for sales in the last three quarters. So, we decided to continue to spend there. And then some of the investment in IT that we would have planned typically to start into the first quarter. We can move some of that up. We feel and accelerated to get the products out even a little faster that are coming up,” said Paychex’s CFO Efrain Rivera in a recent statement.

Strong Earnings

The company has been consistently profitable for a very long time, with the numbers mostly beating the estimates. In the past three years, earnings grew an impressive 10% annually. In the most recent quarter, double-digit revenue growth in the main operating segments of Management Solutions and PEO/Insurance Services drove up total revenues to a record high of $1.27 billion. Consequently, adjusted earnings grew by a fifth to $1.15 per share.


Paychex Q3 2022 Earnings Call Transcript


Encouraged by the stronger-than-expected third-quarter results, the management raised its full-year guidance. Paychex will be publishing fourth-quarter results on June 29 before the opening bell. The consensus estimate is for a 10% increase in earnings to $0.79 per share, on revenues of $1.11 billion.

PAYX experienced high volatility so far this year, but all along maintained a modest uptrend. This week, it traded broadly at the levels seen six months ago. The shares closed Thursday’s regular session slightly lower.

_________________________________________________________________________________________________________________

Stocks you may like:

Apple (AAPL) Stock

Microsoft (MSFT) Stock

Alphabet (GOOGL) Stock

International Business Machines Corp. (IBM) Stock

_________________________________________________________________________________________________________________

Most Popular

Stock Watch: AutoZone (AZO) stays on the fast track despite cost pressures

AutoZone, Inc. (NYSE: AZO) is a much sought-after automotive parts retailer among do-it-yourself customers, especially after the virus-related movement restrictions forced people to stay indoors. The company’s stock has remained

Stock Watch: Intuitive Surgical (ISRG) remains a good bet despite slowdown

Intuitive Surgical, Inc. (NASDAQ: ISRG) is a market leader in the manufacturing and distribution of robotics-assisted surgical systems. The company’s products, designed for minimally invasive surgery, help healthcare professionals conduct procedures

WBA Stock: Why you should add Walgreens Boots to your watchlist

Drugstore chain Walgreens Boots Alliance, Inc. (NASDAQ: WBA) witnessed a spike in customer traffic in the last couple of years due to the vaccination drive and the high demand for

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top